MARC details
000 -LEADER |
fixed length control field |
05016cam a2200553 i 4500 |
001 - CONTROL NUMBER |
control field |
200452150 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20241227162003.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr cnu---unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220603t20222022njua ob 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781119785033 |
Qualifying information |
electronic book |
|
International Standard Book Number |
1119785030 |
Qualifying information |
electronic book |
|
International Standard Book Number |
9781119785019 |
Qualifying information |
electronic book |
|
International Standard Book Number |
1119785014 |
Qualifying information |
electronic book |
|
International Standard Book Number |
9781119785026 |
Qualifying information |
electronic book |
|
International Standard Book Number |
1119785022 |
Qualifying information |
electronic book |
|
Canceled/invalid ISBN |
9781119785002 |
Qualifying information |
paperback |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1327844146 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
Modifying agency |
YDX |
-- |
DG1 |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WK 825 |
Item number |
D536 2022 |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WK 825 |
Item number |
D536 2022EBK |
245 00 - TITLE STATEMENT |
Title |
Diabetes drug notes / |
Statement of responsibility, etc. |
edited by Miles Fisher, Gerard A. McKay, Andrea Llano |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Hoboken, NJ : |
Name of producer, publisher, distributor, manufacturer |
Wiley-Blackwell, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
|
Date of production, publication, distribution, manufacture, or copyright notice |
©2022 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource (xxiv, 368 pages) : |
Other physical details |
illustrations (some color) |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Clinical pharmacology of antidiabetic drugs / Andrea Llano, Gerry McKay, and Ken Paterson -- Metformin / Joseph G. Timmons and James G. Boyle -- Sulfonylureas and meglitinides -- Joseph G. Timmons and James G. Boyle -- DPP-4 inhibitors / Sharon Mackin and Gemma Currie -- SGLT2 inhibitors / Miles Fisher, Andrea Llano, and Gerry McKay -- GLP-1 receptor agonists / Catherine Russell and John R. Petrie -- Animal and human insulin / Ken Paterson -- Short-ccting insulin analogues / Kate Hughes and Gerry McKay -- Long-acting Insulin Analogues / Robert Lindsay -- Devices / David Carty -- Acarbose and alpha glucosidase inhibitors / Miles Fisher -- Glitazones and glitazars / Miles Fisher -- Other antidiabetic drugs / Maroria Oroko, Andrea Llano, and Miles Fisher -- Future antidiabetic drugs / Emma Johns and Miles Fisher -- Guidelines / Miles Fisher and Russell Drummond -- Prescribing antidiabetic drugs / Andrea Llano, Gerry McKay, Frances McManus, Catriona McClements, Joyce McKenzie, and Deborah Morrison |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"At Glasgow Royal Infirmary historically diabetes and clinical pharmacology were linked with specialists in each discipline contributing to one of the medical units in the provision of general medical care to the inhabitants of the east of Glasgow whilst delivering specialist expertise. A few miles north of the Royal Infirmary, Stobhill Hospital in its prime had physicians delivering care who were also delivering academic excellence in the Department of Materia Medica at the University of Glasgow. In 2011 the two hospitals in the northeast of Glasgow merged to provide in patient care on one site and in doing so brought together the prospect of having a combined Department of Diabetes, Endocrinology and Clinical Pharmacology. In addition to having a long-standing reputation for recruiting patients to commercial studies, the Royal Infirmary has strong links with the University of Glasgow, with senior academics continuing to provide both general and specialist patient care, and the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, specifically around training independent pharmacy prescribers. Education and training have been hallmarks of the department and in 2008 a series of Drug Notes was established for Practical Diabetes, covering drugs used in those with diabetes but not necessarily ones for lowering blood glucose, encouraging trainees to be first authors. The series is still going, suggesting that an understanding of drugs is an essential part of being a healthcare provider with an interest in diabetes. Antidiabetic drugs were covered in two separate series for the British Journal of Cardiology, again with trainees aspiring to be specialists in diabetes and endocrinology being first authors and to consider clinical pharmacology as a key knowledge skill"-- |
Assigning source |
Provided by publisher |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Diabetes Mellitus |
General subdivision |
Chemotherapy. |
9 (RLIN) |
120560 |
|
Topical term or geographic name entry element |
Drugs |
9 (RLIN) |
87453 |
|
Topical term or geographic name entry element |
Hypoglycemic Agents |
General subdivision |
pharmacology. |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D007004Q000494 |
|
Topical term or geographic name entry element |
Glycoside Hydrolase Inhibitors |
General subdivision |
pharmacology. |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D065089Q000494 |
|
Topical term or geographic name entry element |
Insulins |
General subdivision |
pharmacology. |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D061385Q000494 |
|
Topical term or geographic name entry element |
Diabetes Mellitus |
General subdivision |
drug therapy. |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D003920Q000188 |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books |
9 (RLIN) |
2032 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Fisher, Miles, |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/nb2003011090 |
Relator term |
editor |
|
Personal name |
McKay, Gerard A., |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2010181936 |
Relator term |
editor |
|
Personal name |
Llano, Andrea, |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2022182238 |
Relator term |
editor |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Wiley Online Library |
Public note |
Connect to resource |
Uniform Resource Identifier |
<a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119785033">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119785033</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |